Menu
Back to Journals » Journal of Asthma and Allergy » Volume 6
Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations
Authors Scichilone N , Spatafora M, Battaglia S, Arrigo, Benfante A , Bellia V
Received 20 February 2013
Accepted for publication 20 February 2013
Published 20 March 2013 Volume 2013:6 Pages 41—42
Corrigendum
Scichilone N, Spatafora M, Battaglia S, Arrigo R, Benfante A, Bellia V. J Asthma Allergy. 2013;6:11–21.
On page 15, the note in the legend for Figure 3 was incorrectly listed as "The improvement is greater in the extra-fine beclomethasone-formoterol combination group than in the non-extra-fine fluticasone propionate-formoterol group". The correct sentence is "The improvement is greater in the extra-fine beclomethasone-formoterol combination group than in the non-extra-fine fluticasone propionate-salmeterol group".
On page 16, there is a missing note for Figure 4.
Note: Data on file. (Chiesi Farmaceutici S.p.A, 2012)
Read the original article
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.